Fig. 2
1
Fig. 2 1 μM ZD (h) - 100 nM Das (h) - 1 - 24 1 24 - - pErk1 pErk2 i) Akt pAkt Colo-357 Panc-1 - - - 1 - 24 1 24 - - 1 2 3 4 5 6 7 8 9 10 Lane ii) Erk1 Erk2 Panc-1 Colo357 HPDEC - - - - - - - 11 12 13 J. Pharmacology and Experimental Therapeutics Enhanced sensitivity of pancreatic cancer cells to concurrent inhibition of aberrant Stat3 and EGFR or Src Soumya Jaganathan, Peibin Yue, and James Turkson
description
Enhanced sensitivity of pancreatic cancer cells to concurrent inhibition of aberrant Stat3 and EGFR or Src. Soumya Jaganathan, Peibin Yue, and James Turkson. J. Pharmacology and Experimental Therapeutics. Fig. 2. Colo357. HPDEC. Panc-1. Panc-1. Colo-357. i). pErk1. pErk2. Erk1. Erk2. - PowerPoint PPT Presentation
Transcript of Fig. 2
Fig. 2
1 μM ZD (h) -100 nM Das (h) -
1-
241 24
--
pErk1pErk2
i)
Akt
pAkt
Colo-357Panc-1
-- -
1-
241 24
--1 2 3 4 5 6 7 8 9 10Lane
ii)
Erk1Erk2
Pan
c-1
Col
o3
57
HP
DE
C
--
--
-- -
11 12 13
J. Pharmacology and Experimental Therapeutics
Enhanced sensitivity of pancreatic cancer cells to concurrent inhibition of aberrant Stat3 and EGFR or Src
Soumya Jaganathan, Peibin Yue, and James Turkson